Goyal Alpesh, Boro Hiya, Khadgawat Rajesh
Endocrinology, All India Institute of Medical Sciences, New Delhi, IND.
Cureus. 2019 Jul 26;11(7):e5248. doi: 10.7759/cureus.5248.
Steroid 11-beta-hydroxylase deficiency is a relatively rare form of congenital adrenal hyperplasia (CAH). We describe the case of a 46,XX child, reared as a male, who first presented to us at the age of three years with features of peripheral precocity and hypokalemic hypertension. Based on the clinical and biochemical profile, a diagnosis of 11-beta-hydroxylase deficiency CAH was established, and physiological glucocorticoid replacement was begun. Both hypertension and hypokalemia improved with glucocorticoid supplementation, and at eight years of age, antihypertensives were successfully withdrawn. Regression of left ventricular hypertrophy was also noted at this time. In keeping with the male gender identity, the child underwent hysterectomy, oopherectomy and breast reduction surgery at 13 years of age. We conclude that both hypertension and end-organ damage due to 11-beta-hydroxylase CAH may get reversed following optimal glucocorticoid treatment. Detailed genital examination at birth may help in early diagnosis of this rare disorder, thereby preventing the deleterious consequences of longstanding mineralocorticoid excess.
类固醇11-β-羟化酶缺乏症是先天性肾上腺皮质增生症(CAH)中一种相对罕见的类型。我们描述了一例46,XX的儿童,自幼被当作男孩抚养,3岁时首次因外周性性早熟和低钾性高血压前来就诊。根据临床和生化特征,确诊为11-β-羟化酶缺乏症CAH,并开始进行生理性糖皮质激素替代治疗。补充糖皮质激素后,高血压和低钾血症均得到改善,8岁时成功停用降压药。此时还发现左心室肥厚有所消退。鉴于其男性性别认同,该患儿在13岁时接受了子宫切除术、卵巢切除术和乳房缩小手术。我们得出结论,经过最佳的糖皮质激素治疗,11-β-羟化酶CAH所致的高血压和终末器官损害可能会得到逆转。出生时进行详细的生殖器检查可能有助于早期诊断这种罕见疾病,从而预防长期盐皮质激素过多带来的有害后果。